These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24053474)

  • 1. Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturing.
    Gatta V; D'Aurora M; Lanuti P; Pierdomenico L; Sperduti S; Palka G; Gesi M; Marchisio M; Miscia S; Stuppia L
    BMC Genomics; 2013 Sep; 14():635. PubMed ID: 24053474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.
    Chu W; Zhang F; Zeng X; He F; Shang G; Guo T; Wang Q; Wu J; Li T; Zhong ZZ; Liang X; Hu J; Liu M
    Stem Cell Res Ther; 2024 May; 15(1):131. PubMed ID: 38702793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
    Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
    Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
    Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
    Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
    Musiał-Wysocka A; Kot M; Sułkowski M; Badyra B; Majka M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
    Pu L; Meng M; Wu J; Zhang J; Hou Z; Gao H; Xu H; Liu B; Tang W; Jiang L; Li Y
    Stem Cell Res Ther; 2017 Mar; 8(1):72. PubMed ID: 28320452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AFM-based Analysis of Wharton's Jelly Mesenchymal Stem Cells.
    Szydlak R; Majka M; Lekka M; Kot M; Laidler P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration.
    Panwar U; Mishra K; Patel P; Bharadva S; Vaniawala S; Shah A; Vundinti BR; Kothari SL; Ghosh K
    Cells Tissues Organs; 2021; 210(4):239-249. PubMed ID: 34521091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.
    Arno AI; Amini-Nik S; Blit PH; Al-Shehab M; Belo C; Herer E; Jeschke MG
    Stem Cells Transl Med; 2014 Mar; 3(3):299-307. PubMed ID: 24436441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells.
    Thakur G; Bok EY; Kim SB; Jo CH; Oh SJ; Baek JC; Park JE; Kang YH; Lee SL; Kumar R; Rho GJ
    Eur J Cell Biol; 2022; 101(3):151245. PubMed ID: 35667339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.